In recent years, targeted drugs against RET proto-oncogene mutations have also been used in clinical practice, and have been proven to have good curative effect in the treatment of MTC patients with RET mutations
In recent years, targeted drugs targeting RET oncogene mutations have been continuously applied in clinical practice, and have been proven to have good efficacy in treating MTC patients with RET mutations
In recent years, targeted drugs for RET proto-oncogene mutation have been continuously applied in clinic, and have been proved to have good curative effect in the treatment of MTC patients with RET mutation.